AFib ablation study halted early – what it means for patients
NCT ID NCT06364215
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two types of heart ablation for people with paroxysmal atrial fibrillation (AFib). One group received standard pulmonary vein isolation, while the other also had the back wall of the left atrium isolated. Both used a newer technique called pulsed-field ablation. The trial was terminated early, so we don't have full results on which approach works better or is safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pulsed-field ablation (device procedure)
What this could lead to
If successful, this could show that adding posterior wall isolation to standard ablation reduces atrial fibrillation recurrence more than standard ablation alone.
What could go wrong
The trial was terminated, so no definitive conclusions can be drawn. It was also a relatively small, single-center study, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION PAROXYSMAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Corewell Health William Beaumont Hospital
Royal Oak, Michigan, 48073, United States
-
Doylestown Hospital
Doylestown, Pennsylvania, 18901, United States
-
Grandview Medical Center
Birmingham, Alabama, 35243, United States
-
HCA Florida Mercy Hospital
Miami, Florida, 33133, United States
-
Lahey Hospital and Medical Center
Burlington, Massachusetts, 01805, United States
-
Maine Medical Center
Portland, Maine, 04102, United States
-
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Methodist Hospital-San Antonio
San Antonio, Texas, 78229, United States
-
North Shore University Hospital, Northwell Health
Manhasset, New York, 11030, United States
-
Orion Medical
Houston, Texas, 77034, United States
-
St. Luke's Boise Medical Center
Boise, Idaho, 83712, United States
-
St. Vincent's Health System, Inc. d/b/a Ascension St. Vincent's
Jacksonville, Florida, 32204, United States
-
The Valley Hospital
Paramus, New Jersey, 07652, United States
-
Trident Medical Center
Charleston, South Carolina, 29406, United States
-
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
-
University of Washington Medical Center
Seattle, Washington, 98195, United States